Predictive Technology Group Inc
OTC:PRED

Watchlist Manager
Predictive Technology Group Inc Logo
Predictive Technology Group Inc
OTC:PRED
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 30k USD

Predictive Technology Group Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Predictive Technology Group Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Predictive Technology Group Inc
OTC:PRED
Revenue
$24.4m
CAGR 3-Years
111%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$59.6B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$29.1B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Revenue
$36B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$11.7B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$14.2B
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
14%
No Stocks Found

Predictive Technology Group Inc
Glance View

Market Cap
30k USD
Industry
Biotechnology

Predictive Technology Group, Inc. engages in the development and commercialization of discoveries and technologies involved in novel molecular diagnostic and pharmaceutical therapeutic and human cells, tissues, and human cellular and tissue-based products. The company is headquartered in Salt Lake City, Utah and currently employs 62 full-time employees. The company went IPO on 2007-07-11. The firm operates through two segments: Human Cell and Tissues Products (HCT/Ps) and diagnostics and therapeutics. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The firm's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. The company offers genetic tests through a number of Advanced Reproductive Technologies (ART) clinics.The Company’s tests include ARTguide and FertilityDX. The RTguide test is a genetic test for women experiencing infertility and other genetic condition.

PRED Intrinsic Value
Not Available

See Also

What is Predictive Technology Group Inc's Revenue?
Revenue
24.4m USD

Based on the financial report for Jun 30, 2020, Predictive Technology Group Inc's Revenue amounts to 24.4m USD.

What is Predictive Technology Group Inc's Revenue growth rate?
Revenue CAGR 3Y
111%

Over the last year, the Revenue growth was -44%. The average annual Revenue growth rates for Predictive Technology Group Inc have been 111% over the past three years .

Back to Top